Search by Drug Name or NDC
NDC 67457-0847-44 OGIVRI Details
OGIVRI
OGIVRI is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is .
MedlinePlus Drug Summary
Trastuzumab injection products are used with other medications or after other medications have been used to treat a certain type of breast cancer that has spread to other parts of the body. Trastuzumab injection products are also used during and after treatment with other medications to decrease the chance that a certain type of breast cancer will return. Trastuzumab injection products are also used with other medications to treat certain types of stomach cancer that have spread to other parts of the body. Trastuzumab is in a class of medications called monoclonal antibodies. It works by stopping the growth of cancer cells.
Related Packages: 67457-0847-44Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Trastuzumab Injection
Product Information
NDC | 67457-0847 |
---|---|
Product ID | 67457-847_b57e61b9-04b7-4d8b-b7c2-be56a060421b |
Associated GPIs | 21170070302120 |
GCN Sequence Number | 077982 |
GCN Sequence Number Description | trastuzumab-dkst VIAL 420 MG INTRAVEN |
HIC3 | V1W |
HIC3 Description | ANTINEOPLASTIC EGF RECEPTOR BLOCKER MCLON ANTIBODY |
GCN | 44158 |
HICL Sequence Number | 044673 |
HICL Sequence Number Description | TRASTUZUMAB-DKST |
Brand/Generic | Brand |
Proprietary Name | OGIVRI |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | trastuzumab |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Mylan Institutional LLC |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA761074 |
Listing Certified Through | n/a |
Package
NDC 67457-0847-44 (67457084744)
NDC Package Code | 67457-847-44 |
---|---|
Billing NDC | 67457084744 |
Package | 1 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20) |
Marketing Start Date | 2019-11-29 |
NDC Exclude Flag | N |
Pricing Information | N/A |